A Chinese research team led by Peking University scientists has developed HEP-50768, a first-in-class drug candidate for chronic itch associated with cholestatic liver disease.
← News
Medicine Breakthroughs Medicine Breakthroughs Health
Scientists develop first-in-class drug candidate for chronic itch
MRGPRX4 Itch Receptor Drug target
HEP-50768 Compound name
Reduced Scratching Behavior Animal efficacy
Filed IND status
Planned Phase I trials
100,000+ molecules screened